Laster, Marciana http://orcid.org/0000-0001-6817-2448
Soohoo, Melissa
Streja, Elani
Elashoff, Robert
Jernigan, Stephanie
Langman, Craig B.
Norris, Keith C.
Salusky, Isidro B.
Kalantar-Zadeh, Kamyar
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK078106, K24-DK091419, R01-DK95668, T32-DK104687)
National Institutes of Health (UL1TR000124, P30AG021684)
Article History
Received: 25 February 2018
Revised: 2 July 2018
Accepted: 7 August 2018
First Online: 29 September 2018
Compliance with ethical standards
: Institutional Review Board approval was obtained from the University of California, Irvine. Given the lack of patient identifiable information and the lack of patient burden, consent was exempted in this study.
: KKZ has received honoraria and/or support from Abbott, Abbvie, Alexion, Amgen, American Society of Nephrology, Astra-Zeneca, AVEO, Chugai, DaVita, Fresenius, Genetech, Haymarket Media, Hospira, Kabi, Keryx, National Institutes of Health, National Kidney Foundation, Relypsa, Resverlogix, Sanofi, Shire, Vifor, and ZS-Pharma. Dr. Isidro B. Salusky is a consultant for Keryx and has received honoraria from Amgen, Abbvie, and OPKO. Dr. Craig B Langman is a consultant for Alexion Pharma Inc., Dicerna Pharma Inc., and Janssen Pharma Inc.